drugset / Trial / NCT00957788
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This research study involves an experimental drug (NST\_001) and a delivery system. The main purpose of this research study is to investigate the safety of NST-001, delivered directly to the inner ear for the treatment of tinnitus.
Timeline
- Start
- 2009-01
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GACYCLIDINE | Small molecule | — | — |